公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2009 | Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage | CHUN-JEN LIU ; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Lee C.-C.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | Journal of Hepatology | 131 | 125 | |
2005 | Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma | Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG ; SUNG-HSIN KUO ; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG | Journal of the National Cancer Institute | 173 | 135 | |
2017 | Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey) | Chuah Y.-Y.; Wu D.-C.; Chuah S.-K.; JYH-CHIN YANG ; Lee T.-H.; Yeh H.-Z.; Chen C.-L.; Liu Y.-H.; Hsu P.-I. | Helicobacter | 17 | 15 |